Some good comments, will try to address each one individually.
GC8 - share consolidation would not change the value of current holders holdings. Only make the SP look "prettier".. not that that's a bad thing..
HaveACrack - Sure but we are pretty bottom of the barrel now.. I think a 20 - 25% discount to the trailing 5 - 10 day price is reasonable.. And note that $750m of debt translates to $750m of equity - from the banks point of view, a lower SP would only mean a marginal gain for them (i.e. marginally "screw" existing holders over).. Considering banks (e.g. MACQ) just took a massive haircut on loans, do you think banks in general are going to quibble over an additional circa 90m of market cap from existing holders? Its like being a billionaire and fighting over 5 cents on the ground.
Croasian - Not sure what you are saying really. If the company does a cap raise (at similar numbers to what I said..), then what do you think that money from the cap raise will be used for ..? obviously to pay of the debt. in effect a cap raise will be similar, if not identical to a d4e swap.
Mike - ...? DSH had a margin of 2 - 3% on their 1.3bn revenue. SGH is capable of margins of 10% +. Are you trying to apply retail margins to a law firm? And yes the cashflow in FY16 was bad for a number of reasons, including a 50m+ "investment" into NIHL. Even the bad quindell business produced a profit last half. The article about pre planned admin is a bit of a joke. especially since multiple vulture funds now own the debt
Nick - see my reply above to have a crack
thestrangesthing - this was a "worst case" scenario. aside from bankruptcy of course
My key assumptions above are the 20c d4e swap, assuming reasonable earnings going forward (circa $100m NPAT), and no bankruptcy. Tinkering with the first two assumptions will provide slightly different results, but overall quite similar.. i.e. a d4e swap will not reduce the SP to say 2 cents..
Anyway that's my thoughts and is largely part of the reason why I still hold. To each their own, but if I see a share with limited downside and considerable upside, seems like a no brainer to buy ..
I also note that this is still the worst scenario WBC and NAB have been "quoted" as not wanting a d4e...
- Forums
- ASX - By Stock
- SGH
- Dilution at this price
SGH
sgh limited
Add to My Watchlist
1.10%
!
$51.40

Dilution at this price, page-58
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$51.40 |
Change
-0.570(1.10%) |
Mkt cap ! $20.91B |
Open | High | Low | Value | Volume |
$52.74 | $52.74 | $51.24 | $18.10M | 351.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 245 | $51.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$51.46 | 1043 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 245 | 51.200 |
1 | 115 | 51.100 |
1 | 55 | 51.010 |
1 | 98 | 50.850 |
1 | 105 | 50.800 |
Price($) | Vol. | No. |
---|---|---|
51.460 | 600 | 1 |
51.590 | 445 | 1 |
52.050 | 500 | 1 |
52.470 | 258 | 1 |
52.700 | 95 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
SGH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online